Detalhe da pesquisa
1.
Post-transplant cyclophosphamide at 80 mg/kg with low dose post-engraftment anti-thymocyte globulin in haploidentical transplantation with myeloablative conditioning.
Bone Marrow Transplant;
2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38600162
2.
A combinatorial therapeutic approach to enhance FLT3-ITD AML treatment.
Cell Rep Med;
4(11): 101286, 2023 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951217
3.
Low Incidence of Relapse with a Moderate Conditioning Regimen of Fludarabine, Busulfan, and Melphalan for Patients with Myeloid Malignancies: A Single-Center Analysis of 100 Patients.
Transplant Cell Ther;
29(8): 512.e1-512.e8, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37263418
4.
Post-transplantation cyclophosphamide combined with tacrolimus and low-dose post-engraftment anti-thymoglobulin as GVHD prophylaxis for patients undergoing peripheral blood stem cell transplantation from haploidentical family donor: A single center analysis.
Front Med (Lausanne);
10: 1140217, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37064033
5.
Clinical Significance of Haplo-Fever and Cytokine Profiling After Graft Infusion in Allogeneic Stem Cell Transplantation From Haplo-Identical Donors.
Front Med (Lausanne);
9: 820591, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35463028
6.
Chemotherapy or Allogeneic Stem Cell Transplantation as Salvage Therapy for Patients with Refractory Acute Myeloid Leukemia: A Multicenter Analysis.
Acta Haematol;
145(4): 419-429, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35231903
7.
Cladribine-based debulking chemotherapy sequential with reduced intensity regimen and post-transplantation maintenance for refractory myeloid leukemia: a prospective phase II clinical trial.
Bone Marrow Transplant;
57(6): 1004-1006, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35352037
8.
Double alkylators based conditioning reduced the relapse rate after allogeneic peripheral blood stem cell transplantation in adult patients with myeloid malignancies: a single arm phase II study.
Bone Marrow Transplant;
57(5): 843-845, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35332301
9.
Feasibility and safety of EUS-guided radiofrequency ablation in treatment of locally advanced, unresectable pancreatic cancer.
Endosc Ultrasound;
10(5): 398-399, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34003141
10.
Post-transplantation Cyclophosphamide, Tacrolimus and Low-Dose ATG as GVHD Prophylaxis for Allogeneic Peripheral Stem Cell Transplantation for Adult Patients With Lymphoid Malignancies: A Single Arm Phase II Study.
Front Med (Lausanne);
8: 630160, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33816524
11.
Low-Dose Decitabine Monotherapy Reverses Mixed Chimerism in Adult Patients After Allogeneic Hematopoietic Stem Cell Transplantation With Myeloablative Conditioning Regimen: A Pilot Phase II Study.
Front Med (Lausanne);
8: 627946, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33708780
12.
Presence and persistence of hepatitis E virus RNA and proteins in human bone marrow.
Emerg Microbes Infect;
9(1): 994-997, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32366181
13.
FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia.
Blood;
135(17): 1472-1483, 2020 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32315388
14.
Cord blood infusion-accelerated hematopoietic recovery after combined immunosuppressive therapy with fludarabine and rabbit ATG in severe aplastic anemia.
Int J Hematol;
111(3): 360-368, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31900878
15.
NRF2 -617 C/A Polymorphism Impacts Proinflammatory Cytokine Levels, Survival, and Transplant-Related Mortality After Hematopoietic Stem Cell Transplantation in Adult Patients Receiving Busulfan-Based Conditioning Regimens.
Front Pharmacol;
11: 563321, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33384597
16.
Donor Allospecific CD44high Central Memory T Cells Have Decreased Ability to Mediate Graft-vs.-Host Disease.
Front Immunol;
10: 624, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31001254
17.
High-dose etoposide could discriminate the benefit from autologous peripheral blood stem cell transplantation in the patients with refractory diffuse large B cell lymphoma.
Ann Hematol;
98(4): 823-831, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30715566
18.
Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malignancies: a prospective, phase II study.
Bone Marrow Transplant;
54(7): 1049-1057, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30446741
19.
Bacterial Pathogens Differed Between Neutropenic and Non-neutropenic Patients in the Same Hematological Ward: An 8-Year Survey.
Clin Infect Dis;
67(suppl_2): S174-S178, 2018 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30423039
20.
Early tapering of immunosuppressive agents after HLA-matched donor transplantation can improve the survival of patients with advanced acute myeloid leukemia.
Ann Hematol;
97(3): 497-507, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29250743